DJS Law Group says PROCEPT BioRobotics investors may contact firm in securities case

DJS Law Group said investors in PROCEPT BioRobotics Corp. may have claims in a securities class action that alleges false and misleading statements tied to sales practices and inventory levels.

DJS Law Group says PROCEPT BioRobotics investors may contact firm in securities case

DJS Law Group says shareholders who bought PROCEPT BioRobotics stock during a stated class period may contact the firm about a securities class action tied to allegations of misleading market statements.

DJS Law Group said in a PR Newswire release dated Aug. 13, 2026, that it is notifying investors about a securities class action involving PROCEPT BioRobotics Corporation, which trades on Nasdaq under the ticker PRCT. The release says the case concerns shareholders who purchased PRCT shares from Feb. 28, 2024, through Feb. 25, 2026.

According to the release, the complaint alleges violations of Section 10(b), Section 20(a) and SEC Rule 10b-5. Those provisions are part of federal securities law and are commonly cited in cases that claim a company misled investors.

The press release says the complaint alleges PROCEPT made false and misleading statements to the market. The stated theory is that the company inflated revenue by using aggressive discounting to pull sales forward from future periods. The release says that discounting also created a glut of inventory in the market, making the company's public statements false and materially misleading during the class period.

The release identifies the company as PROCEPT BioRobotics Corporation, also called Procept. It says shareholders who bought shares during the class period are encouraged to contact DJS Law Group about possible lead plaintiff appointments. The firm says lead plaintiff status is not required to participate in any recovery.

DJS Law Group described itself in the release as focused on investor return through balanced counseling and aggressive advocacy. It said the firm handles securities class actions, corporate governance litigation and domestic and international M&A appraisals.

The release does not announce a court ruling or settlement. It is a notice to investors about the pending case and the chance to seek lead plaintiff status. The complaint's allegations remain claims as presented by the firm in the press release.

What happens next depends on the progress of the lawsuit and whether investors choose to contact the firm about the case. The release does not give a timetable for court action or any deadlines beyond the stated class period.

Sources

Editorial note: This article was prepared with AI assistance and includes source attribution for reader review.

▶ View the Web Story
A visual, tap-through version of this report.